Literature DB >> 12152784

Tin-protoporphyrin prevents experimental superficial siderosis in rabbits.

Arnulf H Koeppen1, Andrew C Dickson.   

Abstract

Superficial siderosis of the human central nervous system is caused by small continuous or recurrent subarachnoid hemorrhages that lead to the destructive deposition of hemosiderin. The excessive tissue iron derives from heme that is oxidized in a rate-limiting step by the enzyme heme oxygenase (HO), and especially the inducible form, HO-1. We postulated that competitive inhibition of HO by tin-protoporphyrin IX (SnPP) could prevent experimental superficial siderosis. Since synthetic metalloporphyrins do not cross the blood-brain barrier, SnPP was delivered directly into the cisterna magna. Rabbits received weekly intracisternal injections of washed autologous red blood cells (RBC) over a period of 1 to 16 wk. In companion experiments, SnPP was added to the suspension of RBC, or SnPP was injected without RBC. All injections caused increased HO-1 immunoreactivity in the Bergmann glia of the cerebellar cortex and in superficial astrocytes of the piriform cortex. The injections of RBC or RBC with added SnPP also generated a vigorous microglial response. The metalloporphyrin entered the tissue in inhibitory amounts and greatly reduced the accumulation of histochemically detectable iron. It did not alter the microglial response. The observations allowed the conclusion that SnPP suppressed heme oxidation but did not affect other steps in the pathogenesis of superficial siderosis.

Entities:  

Mesh:

Substances:

Year:  2002        PMID: 12152784     DOI: 10.1093/jnen/61.8.689

Source DB:  PubMed          Journal:  J Neuropathol Exp Neurol        ISSN: 0022-3069            Impact factor:   3.685


  7 in total

1.  Superficial siderosis associated with abundant τ and α-synuclein accumulation.

Authors:  Masaki Takao; Shigeo Murayama; Youji Yoshida; Ban Mihara
Journal:  BMJ Case Rep       Date:  2011-12-01

2.  Heme oxygenase activity and hemoglobin neurotoxicity are attenuated by inhibitors of the MEK/ERK pathway.

Authors:  Jing Chen-Roetling; Zhi Li; Mai Chen; Olatilewa O Awe; Raymond F Regan
Journal:  Neuropharmacology       Date:  2009-02-06       Impact factor: 5.250

3.  Iron localization in superficial siderosis of the central nervous system.

Authors:  Harry Kellermier; Guoji Wang; Clayton Wiley
Journal:  Neuropathology       Date:  2008-08-07       Impact factor: 1.906

4.  Iron and iron-responsive proteins in the cardiomyopathy of Friedreich's ataxia.

Authors:  Susan Michael; Simone V Petrocine; Jiang Qian; Jacques B Lamarche; Mitchell D Knutson; Michael D Garrick; Arnulf H Koeppen
Journal:  Cerebellum       Date:  2006       Impact factor: 3.847

5.  Asymptomatic superficial siderosis after posterior fossa tumor resection: illustrative case.

Authors:  Anshit Goyal; Cody L Nesvick; Joshua A Spear; David J Daniels
Journal:  J Neurosurg Case Lessons       Date:  2021-05-03

6.  Agranulocytosis with deferiprone treatment of superficial siderosis.

Authors:  Nikhil Huprikar; Marisa Gossweiler; Maureen Callaghan; Paul Bunge
Journal:  BMJ Case Rep       Date:  2013-08-07

7.  Heme Oxygenase 1 in Schwann Cells Regulates Peripheral Nerve Degeneration Against Oxidative Stress.

Authors:  Muwoong Kim; Hyosun Kim; Dogyeong Kim; Dokyoung Kim; Youngbuhm Huh; Chan Park; Hyung-Joo Chung; Junyang Jung; Na Young Jeong
Journal:  ASN Neuro       Date:  2019 Jan-Dec       Impact factor: 4.146

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.